Carlsmed
ACQUIRED (1).png
Personalized 3D printed
surgical implants
INVESTMENt

June, 2020

Sector

Med-Tech

FUND

Fund I

location

Southern California

co-investors

Cove Fund
Saccharo Ventures
Device of Tomorrow Capital
EvoNexus

Image-empty-state_edited.jpg

Mike Cordonnier

CEO

Quintuple aim
Alertive.png

Carlsmed is pioneering the treatment of adult spinal deformity with aprevo™, the first available breakthrough technology in spine. Carlsmed uses proprietary algorithms and imaging data to create surgeon-specific and patient-specific surgical plans, and manufactures personalized 3D printed spinal devices to achieve each plan.